Navigating the CMS 14-Day Rule in Biomarker Testing

David L. Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

Related Videos

November 3, 2014

Referrals for Patients with Polycythemia Vera

Dr. Mesa describes why patients with PV who have a broad and heterogeneous course should seek a referral from a specialty center.Supported through funding from Incyte

August 15, 2013

Treating Cancer: A Changing Paradigm

Dr. Vij delves into the role of bioinformatics in identifying targets for drug development.